Analytical Data
-
基因名
tktA
- Application
-
别名
tktA; tkt; b2935; JW5478; Transketolase 1; TK 1; EC 2.2.1.1
-
种属
Escherichia coli
-
表达系统
E. coli
-
标签
N- His-SUMO
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P27302
-
表达区间
1-663aa
-
分子量
88.2 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The TktA protein, also known as transketolase A, is an important enzyme involved in the pentose phosphate pathway, a crucial metabolic pathway in many organisms, including bacteria and plants. This pathway plays a vital role in generating NADPH and ribose-5-phosphate, which are essential for biosynthesis and cellular redox balance. Research on TktA has gained attention due to its potential applications in biotechnology and medicine. For instance, the manipulation of this enzyme could enhance the production of valuable metabolites, such as aromatic compounds and biofuels, through metabolic engineering. Furthermore, understanding the structure-function relationship of TktA can provide insights into its catalytic mechanism and regulation, offering opportunities for the development of inhibitors that could have therapeutic implications in diseases where metabolic pathways are dysregulated. Studies have focused on the recombinant expression, purification, and characterization of TktA, utilizing various expression systems like E. coli. The introduction of site-directed mutagenesis has also enabled researchers to investigate the impact of specific amino acid residues on enzyme activity and stability. Overall, the exploration of TktA as a recombinant protein not only contributes to our fundamental understanding of metabolic processes but also holds significant promise for industrial applications and the development of novel therapeutic strategies.












